Physician profile
Ryan Scully
NPI 1063775351
$42,999.48
in general payments reported to CMS, 2019-2025
5 companies · $10K in 2025
The $10K reported for 2025 was more than what 76% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $752 · 2022: $1,200 · 2023: $11K · 2024: $20K · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $30K · Education: $10K · Food and Beverage: $1,047.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $30,000.00 |
| Education | $10,000.00 |
| Food and Beverage | $1,047.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $40,105.43 | 2023-2025 | Real Intelligence, Ri Hip Navigation, Journey |
| Impactortho, INC. | $1,952.34 | 2020-2022 | |
| Zimmer Biomet Holdings, INC. | $724.59 | 2023-2024 | Rosa, Persona, G7 |
| Biocomposites INC | $166.96 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $50.16 | 2025 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Scully listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.